Search Within

Shakeel Modak

  1. "Elsevier Inc."
Formats
  1. Journal Article (13)
  2. Meeting Abstract (9)
  3. Book Section (1)
Groups
  1. Neuroblastoma Service (23)
  2. Pediatrics, Department of (23)
  3. Center for Hematologic Malignancies (18)
  4. Pediatric Leukemia (18)
  5. Radiation Oncology, Department of (16)
  6. Survivorship Research (16)

More Groups

People
  1. Brian Kushner (18)
  2. Suzanne Wolden (16)
  3. Nai-Kong Cheung (15)
  4. Michael La Quaglia (13)
  5. Dana Casey (8)
  6. Kim Kramer (6)

More People

Years
  1. 2024 (2)
  2. 2019 (2)
  3. 2018 (1)
  4. 2017 (4)
  5. 2016 (4)
  6. 2015 (1)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (15)
  2. European Journal of Cancer (3)
  3. Cancer Treatment Reviews (1)
  4. Neuroblastoma: Molecular Mechanisms and Therapeutic Interventions (1)
  5. Practical Radiation Oncology (1)
  6. Seminars in Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (23)

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reduced-dose radiation therapy for high-risk neuroblastoma: Results from a prospective clinical trial
    Meeting Abstract

    Jackson, C.; Modak, S.; LaQuaglia, M. P.; Kushner, B.; Gerstle, J. T.; Basu, E.; Cheung, N. K.; Iglesias-Cardenas, F.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Intraoperative radiation therapy for relapsed or refractory high-risk neuroblastoma: A 27-year experience
    Journal Article

    Conte, B.; Casey, D. L.; Tringale, K. R.; Honeyman, J.; Narayan, N. J. C.; LaQuaglia, M. P.; Gerstle, J. T.; Modak, S.; Kushner, B. H.; Kramer, K.; more...
    Practical Radiation Oncology (2024)

    Fulltext@MSK | Save
  • Immunotherapy for neuroblastoma
    Book Section

    Kudva, A.; Modak, S.
    In Ray, S. K. (Eds.) Neuroblastoma: Molecular Mechanisms and Therapeutic Interventions (2019)

    Fulltext@MSK | Save
  • Reduced-dose radiation therapy to the primary site is effective for high-risk neuroblastoma: Results from a prospective trial
    Journal Article

    Casey, D. L.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; Roberts, S. S.; LaQuaglia, M. P.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Radiation therapy to sites of metastatic disease as part of consolidation in high-risk neuroblastoma: Can long-term control be achieved?
    Journal Article

    Casey, D. L.; Pitter, K. L.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; LaQuaglia, M. P.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Dose escalation is needed for gross disease in high-risk neuroblastoma
    Meeting Abstract

    Casey, D. L.; Kushner, B.; Cheung, N. K.; Modak, S.; La Quaglia, M. P.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Local control with reduced-dose radiation therapy for high-risk neuroblastoma: Results from a prospective trial
    Meeting Abstract

    Casey, D. L.; Kushner, B.; Cheung, N. K.; Modak, S.; La Quaglia, M. P.; Basu, E.; Roberts, S.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Radiation therapy to sites of metastatic disease as part of consolidation in high-risk neuroblastoma: Can long-term control be achieved?
    Meeting Abstract

    Casey, D. L.; Kushner, B.; Cheung, N. K.; Modak, S.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Renal function outcomes of high-risk neuroblastoma patients undergoing radiation therapy
    Journal Article

    Beckham, T. H.; Casey, D. L.; LaQuaglia, M. P.; Kushner, B. H.; Modak, S.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population
    Meeting Abstract

    Fischer, M.; Wulff, B.; Baruchel, S.; Berlanga, P.; Trahair, T.; Mechinaud, F.; Schulte, J.; Modak, S.; Merks, J. H.; Zwaan, C. M.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save